Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain

被引:464
作者
Zhu, Y
Romero, MI
Ghosh, P
Ye, ZY
Charnay, P
Rushing, EJ
Marth, JD
Parada, LF [1 ]
机构
[1] Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr, Basic Res Nerve Growth & Regenerat, Dallas, TX 75390 USA
[3] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA
[4] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA
关键词
neurofibromatosis; tumor suppressor; animal models; knockouts; astrogliosis;
D O I
10.1101/gad.862101
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Neurofibromatosis type 1 (NF1) is a prevalent genetic disorder that affects growth properties of neural-crest-derived cell populations. In addition, approximately one-half of NF1 patients exhibit learning disabilities. To characterize NF1 function both in vitro and in vivo, we circumvent the embryonic lethality of NF1 null mouse embryos by generating a conditional mutation in the NF1 gene using Cre/loxP technology. Introduction of a Synapsin I promoter driven Cre transgenic mouse strain into the conditional NF1 background has ablated NF1 function in most differentiated neuronal populations. These mice have abnormal development of the cerebral cortex, which suggests that NF1 has an indispensable role in this aspect of CNS development. Furthermore, although they are tumor free, these mice display extensive astrogliosis in the absence of conspicuous neurodegeneration or microgliosis. These results indicate that NF1-deficient neurons are capable of inducing reactive astrogliosis via a non-cell autonomous mechanism.
引用
收藏
页码:859 / 876
页数:18
相关论文
共 80 条
[1]   GAPIII A NEW BRAIN-ENRICHED MEMBER OF THE GTPASE-ACTIVATING PROTEIN FAMILY [J].
BABA, H ;
FUSS, B ;
URANO, J ;
POULLET, P ;
WATSON, JB ;
TAMANOI, F ;
MACKLIN, WB .
JOURNAL OF NEUROSCIENCE RESEARCH, 1995, 41 (06) :846-858
[2]   THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO MAMMALIAN GAP AND YEAST IRA PROTEINS [J].
BALLESTER, R ;
MARCHUK, D ;
BOGUSKI, M ;
SAULINO, A ;
LETCHER, R ;
WIGLER, M ;
COLLINS, F .
CELL, 1990, 63 (04) :851-859
[3]   ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715
[4]   PROTEINS REGULATING RAS AND ITS RELATIVES [J].
BOGUSKI, MS ;
MCCORMICK, F .
NATURE, 1993, 366 (6456) :643-654
[5]   Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells [J].
Bollag, G ;
Clapp, DW ;
Shih, S ;
Adler, F ;
Zhang, YY ;
Thompson, P ;
Lange, BJ ;
Freedman, MH ;
McCormick, F ;
Jacks, T ;
Shannon, K .
NATURE GENETICS, 1996, 12 (02) :144-148
[6]  
BOS JL, 1989, CANCER RES, V49, P4682
[7]  
BOUME HR, 1990, NATURE, V348, P125
[8]   TARGETED DISRUPTION OF THE NEUROFIBROMATOSIS TYPE-1 GENE LEADS TO DEVELOPMENTAL ABNORMALITIES IN HEART AND VARIOUS NEURAL CREST-DERIVED TISSUES [J].
BRANNAN, CI ;
PERKINS, AS ;
VOGEL, KS ;
RATNER, N ;
NORDLUND, ML ;
REID, SW ;
BUCHBERG, AM ;
JENKINS, NA ;
PARADA, LF ;
COPELAND, NG .
GENES & DEVELOPMENT, 1994, 8 (09) :1019-1029
[9]   SEQUENCE HOMOLOGY SHARED BY NEUROFIBROMATOSIS TYPE-1 GENE AND IRA-1 AND IRA-2 NEGATIVE REGULATORS OF THE RAS CYCLIC-AMP PATHWAY [J].
BUCHBERG, AM ;
CLEVELAND, LS ;
JENKINS, NA ;
COPELAND, NG .
NATURE, 1990, 347 (6290) :291-294
[10]   A MAJOR SEGMENT OF THE NEUROFIBROMATOSIS TYPE-1 GENE - CDNA SEQUENCE, GENOMIC STRUCTURE, AND POINT MUTATIONS [J].
CAWTHON, RM ;
WEISS, R ;
XU, GF ;
VISKOCHIL, D ;
CULVER, M ;
STEVENS, J ;
ROBERTSON, M ;
DUNN, D ;
GESTELAND, R ;
OCONNELL, P ;
WHITE, R .
CELL, 1990, 62 (01) :193-201